J M Holly - JoVE Visualize

Showing results (81-90 of 132) with videos related to

Pageof 14

Sort By:

Clinical Endocrinology|July 9, 1999

Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndromeV Mohamed-Ali, J H Pinkney, A Panahloo, et al.

Arthritis and Rheumatism|October 19, 1999

Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee jointsJ K Fernihough, R S Richmond, C S Carlson, et al.

Acta Paediatrica Scandinavica. Supplement|January 1, 1991

Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetesD B Dunger, J A Edge, R Pal, et al.

The Journal of Clinical Endocrinology and Metabolism|June 1, 1996

Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancerV J Frost, S I Helle, P E Lønning, et al.

Clinical Endocrinology|July 1, 1996

Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitusC L Acerini, K L Clayton, R Hintz, et al.

Endocrinology|December 1, 1998

Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluidL A Maile, S Xu, S C Cwyfan-Hughes, et al.

The Journal of Clinical Endocrinology and Metabolism|March 7, 2001

The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapyS I Helle, T Ueland, D Ekse, et al.

International Journal of Cancer|October 31, 2000

Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cellsC A Fowler, C M Perks, P V Newcomb, et al.

The Journal of Endocrinology|November 1, 1991

The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemiaA M Cotterill, J M Holly, S C Davies, et al.

Cancer Research|January 26, 2000

Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cellsA C Williams, T J Collard, C M Perks, et al.

Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:

Pageof 14

Clinical Endocrinology|July 9, 1999

Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndromeV Mohamed-Ali, J H Pinkney, A Panahloo, et al.

Arthritis and Rheumatism|October 19, 1999

Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee jointsJ K Fernihough, R S Richmond, C S Carlson, et al.

Acta Paediatrica Scandinavica. Supplement|January 1, 1991

Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetesD B Dunger, J A Edge, R Pal, et al.

The Journal of Clinical Endocrinology and Metabolism|June 1, 1996

Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancerV J Frost, S I Helle, P E Lønning, et al.

Clinical Endocrinology|July 1, 1996

Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitusC L Acerini, K L Clayton, R Hintz, et al.

Endocrinology|December 1, 1998

Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluidL A Maile, S Xu, S C Cwyfan-Hughes, et al.

The Journal of Clinical Endocrinology and Metabolism|March 7, 2001

The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapyS I Helle, T Ueland, D Ekse, et al.

International Journal of Cancer|October 31, 2000

Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cellsC A Fowler, C M Perks, P V Newcomb, et al.

The Journal of Endocrinology|November 1, 1991

The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemiaA M Cotterill, J M Holly, S C Davies, et al.

Cancer Research|January 26, 2000

Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cellsA C Williams, T J Collard, C M Perks, et al.

Pageof 14